The focus keyword XRP ETF takes center stage as optimism around its approval in 2025 gains significant traction. Recent developments have triggered a surge in market confidence, with many speculating that a greenlight could be just around the corner despite regulatory delays.
The focus keyword XRP ETF takes center stage as optimism around its approval in 2025 gains significant traction. Recent developments have triggered a surge in market confidence, with many speculating that a greenlight could be just around the corner despite regulatory delays.
Investors and crypto enthusiasts are keeping a close eye on Polymarket, a prediction platform whose confidence in a Ripple ETF approval saw a sharp rise earlier this month. According to updates from known XRP advocate John Squire, predictions soared to a remarkable 98% likelihood of approval by year-end. Just weeks before, the odds had slipped below 70%, marking the recent increase as a significant shift in sentiment.
Although the percentage has slightly receded to 88% at present, it still stands far above the yearly average. However, expectations remain cautious as the chance of SEC approval by the immediate July 31 milestone sits at a modest 17%. This decrease reflects ongoing uncertainties and lack of further progress other than continued application delays by the U.S. Securities and Exchange Commission.
What makes Polymarket’s momentum particularly compelling is the platform’s proven accuracy. Research from earlier this year points to a track record boasting a 90% success rate in predicting outcomes within the crypto space. This lends notable weight to the current market outlook for an XRP ETF.
Why Enthusiasm for an XRP ETF Peaked
The dramatic surge in confidence appears to coincide directly with a pivotal move by the SEC: the approval of a NASDAQ-based cryptocurrency settlement price index. This benchmark includes XRP alongside other leading altcoins such as ADA, SOL, and XLM. Industry interpreters view the approval as crucial, offering clear evidence of these assets’ market maturity in terms of liquidity and pricing integrity.
This signals a shift in regulatory tone and removes significant barriers to ETF approval. By officially recognizing complex benchmarks involving altcoins, the SEC may be laying the groundwork for more inclusive financial products tied to digital assets beyond Bitcoin and Ethereum.
Despite XRP’s heightened outlook, counterparts like Cardano and Solana haven’t enjoyed the same bump in ETF odds. Cardano’s projected approval chances have tapered off to 42%, down substantially from previous levels near 70%. Solana’s trajectory, while stronger at 79%, still reflects a downward trend compared to prior expectations.
Nonetheless, momentum around a Ripple ETF continues to grow, fueled by a mix of market enthusiasm, strong performance on forecasting platforms, and a potential softening of SEC opposition. The narrative suggests that for XRP, the question may no longer be if but when such a financial product receives regulatory blessing.
Related: Expert Advice: Sell XRP If You’re Confused
As attention shifts further into 2025, investors are likely to track how U.S. regulators follow up this milestone NASDAQ index decision and whether it becomes the catalyst for a broader range of spot cryptocurrency ETF approvals.
Quick Summary
The focus keyword XRP ETF takes center stage as optimism around its approval in 2025 gains significant traction. Recent developments have triggered a surge in market confidence, with many speculating that a greenlight could be just around the corner despite regulatory delays.
Source
Information sourced from official Ripple publications, institutional research, regulatory documentation and reputable crypto news outlets.
Author
Ripple Van Winkle is a cryptocurrency analyst and founder of XRP Right Now. He has been active in the crypto space for over 8 years and has generated more than 25 million views across YouTube covering XRP daily.
Editorial Note
Opinions are the author's alone and for informational purposes only. This publication does not provide investment advice.

